Interchangeability In Biosimilars
Maia Kayal, MD, MS, defines interchangeability and reviews the requirements from the FDA, "switching studies," and meaningful difference verses class effect.
Source: ajmc.com
Page 2 - Reference Product News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Reference Product. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Reference Product Today - Breaking & Trending Today
Challenges Payers Face With Biosimilars
Kimberly C. Chen DO, MSHLM, and Maia Kayal, MD, MS, review the challenges related to biosimilars from the payer perspective and strategies payers may employ to help improve the uptake of biosimilars.
Source: ajmc.com
Challenges Associated With Biosimilars
Jonathan Kay, MD, discusses challenges that patients may experience related to biosimilars for inflammatory conditions
Source: ajmc.com
Savings Potential With Biosimilars
Jonathan Kay, MD, and Kimberly C. Chen DO, MSHLM, define what a biosimilar is and discuss the potential for a lower cost than the reference product.
Source: ajmc.com
BPCIA Litigation Update: Amgen v. Sandoz in the District of New Jersey | Rothwell, Figg, Ernst & Manbeck, P.C.
As one BPCIA case came to a close in May, another got underway. On May 1, 2023, Amgen filed a complaint in the District of New Jersey, accusing Sandoz of infringing patents that relate...
Source: jdsupra.com